Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen
about
Recent vaccine technology in industrial animalsPlant-produced viral bovine vaccines: what happened during the last 10 years?Hepatitis A virus and the origins of picornaviruses.A modular and compact portable mini-endstation for high-precision, high-speed fixed target serial crystallography at FEL and synchrotron sources.A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid ParticlesStructure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine designTruncated Bovine Integrin Alpha-v/Beta-6 as a Universal Capture Ligand for FMD Diagnosis.Assembly of recombinant Israeli Acute Paralysis Virus capsids.Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids.Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.The use of noncrystallographic symmetry averaging to solve structures from data affected by perfect hemihedral twinning.Processing of the VP1/2A junction is not necessary for production of foot-and-mouth disease virus empty capsids and infectious viruses: characterization of "self-tagged" particles.Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine design.Bioengineering virus-like particles as vaccines.Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines.Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens.Adjuvants for foot-and-mouth disease virus vaccines: recent progress.Three-dimensional structure of foot-and-mouth disease virus and its biological functions.Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in CattleFoot-and-mouth disease vaccines: progress and problems.SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased ThermostabilityThe B-cell response to foot-and-mouth-disease virus in cattle following vaccination and live-virus challenge.Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines.The pH Stability of Foot-and-Mouth Disease Virus Particles Is Modulated by Residues Located at the Pentameric Interface and in the N Terminus of VP1.Influence of protein fold stability on immunogenicity and its implications for vaccine design.Exploiting fast detectors to enter a new dimension in room-temperature crystallography.Equine Rhinitis A Virus Mutants with Altered Acid Resistance Unveil a Key Role of VP3 and Intrasubunit Interactions in the Control of the pH Stability of the Aphthovirus Capsid.Antigenic diversification is correlated with increased thermostability in a mammalian virus.Assembly, Engineering and Applications of Virus-Based Protein Nanoparticles.Prediction of stability changes upon mutation in an icosahedral capsid.Structures of foot and mouth disease virus pentamers: Insight into capsid dissociation and unexpected pentamer reassociation.Comparison of strategies for the production of FMDV empty capsids using the baculovirus vector system.The Diamond Light Source and the challenges ahead for structural biology: some informal remarks.All-atom molecular dynamics calculation study of entire poliovirus empty capsids in solution.Immunogenicity of the capsid precursor and a nine-amino-acid site-directed mutant of the 3C protease of foot-and-mouth disease virus coexpressed by a recombinant goatpox virus.Cryo-EM Structure of Seneca Valley Virus Procapsid.Crystal structure of NucB, a biofilm-degrading endonuclease.Recent advances in veterinary applications of structural vaccinology.Minimally processed crude leaf extracts of containing recombinant foot and mouth disease virus-like particles are immunogenic in miceFoot-and-Mouth Disease
P2860
Q26766625-78D761FE-2CF1-4B74-9806-BC5621E69118Q26801335-5C4C0780-9998-4292-BCAE-D35BAE6C4506Q27317117-CB1C5C33-4085-4E0A-A474-B57730CED414Q27317223-9EA01EA5-6474-402A-BA0D-989C8A36782EQ27339522-3ECB47AE-351C-4B84-A000-3E7FB2D9E51AQ27702186-C84AD09C-D4F5-423C-B8B3-9DD7FF98E71BQ30151862-857DF4A6-9A8D-4828-AA50-28AF2D027561Q34083988-1FFE3CB2-B53C-4D43-97F4-6AB81FE5BD2CQ34974075-7E162878-5521-4C8A-B0F9-1FD84D4EF7B4Q35760496-E816FB87-880A-4A5E-ADEE-F1671EA2E62FQ35937441-A1D63A4B-ED3E-4BD5-9F05-0F47F3756B2BQ37252816-B92054E0-CC4E-4559-AD91-BDFB2BB1FEF0Q37417999-E763BFB2-52DB-4770-9947-37ACF9C2E831Q38172045-294223E4-1E61-4DD7-A000-F7BB17757C1BQ38184579-EFB0B9B1-C977-4E6F-978C-D646FFB5259AQ38243160-254E8C18-669D-43B2-AC7C-97733033F177Q38252451-107F24AC-CB92-4B5C-9D38-354122116E7BQ38265915-FA63226E-C9F3-4223-9331-8120313717F5Q38280242-52EC9C0C-E0B5-4116-A923-A6153DFE28A9Q38694452-DF32C3EE-C7C7-4CC8-B211-7A7786C33FBBQ38744534-059BCF3C-3732-4C20-8915-FEC42FF35C03Q38766380-68603A21-4A7E-4968-A193-04DC2D8A47CAQ38851217-FAD60512-103A-4DAB-A47C-AD7A8D406CA1Q38900868-D804CCC2-BF5B-44B4-8997-FADE1E661247Q39177220-E7C48F76-53E9-4670-9F34-82AA2E0612D7Q39374464-C6336A2E-044D-4FDB-8462-66350664F689Q39480511-D3762392-3EBD-4ADF-B0E0-CBC7A19EB592Q39655282-9BE682A1-4005-42A1-870E-17D59073C6F7Q40525635-49B7EC0B-C76B-4696-BAC0-7478A287FFEFQ41882635-A4CED783-F0B7-4367-95AB-85562B4B05AEQ41932151-CCD2DCCB-EFD8-4855-B8C9-D9414871B89DQ42002998-2A1FBE08-40E5-407D-ACE6-A2508876EF55Q42069819-88AB5876-4AEE-4EC2-9F3E-6C68D6837DD7Q42182372-C2ADD388-BADD-48EE-9823-41F4450867F8Q42240435-E921F25F-2853-4C04-927C-BE9DCDDAEF9AQ47269211-04B84AC9-15FF-4BA7-989C-AF4FA113D0DCQ47373910-069073F1-4C77-415A-BADB-78267CA0DF5FQ52650429-F50FF1AC-8B59-45B6-8251-E5B71ACBA813Q57489969-70970D43-E8B8-439F-8294-A1E8F6D01E8BQ58693361-E0E9FB62-80C1-4900-84FF-84463CD616EB
P2860
Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Rational Engineering of Recomb ...... fe, Protective Vaccine Antigen
@ast
Rational Engineering of Recomb ...... fe, Protective Vaccine Antigen
@en
Rational Engineering of Recomb ...... fe, Protective Vaccine Antigen
@nl
type
label
Rational Engineering of Recomb ...... fe, Protective Vaccine Antigen
@ast
Rational Engineering of Recomb ...... fe, Protective Vaccine Antigen
@en
Rational Engineering of Recomb ...... fe, Protective Vaccine Antigen
@nl
prefLabel
Rational Engineering of Recomb ...... fe, Protective Vaccine Antigen
@ast
Rational Engineering of Recomb ...... fe, Protective Vaccine Antigen
@en
Rational Engineering of Recomb ...... fe, Protective Vaccine Antigen
@nl
P2093
P2860
P50
P3181
P1433
P1476
Rational Engineering of Recomb ...... fe, Protective Vaccine Antigen
@en
P2093
Alison Burman
Claudine Porta
Silvia Loureiro
Terry Jackson
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1003255
P577
2013-03-01T00:00:00Z